Literature DB >> 30265651

Correlation between the blood level of irisin and the severity of acute myocardial infarction in exercise-trained rats.

Shaimaa M Bashar1, Shereen M Samir El-Sherbeiny1,2, Mohamed Z Boraie1.   

Abstract

Background Acute myocardial infarction is a major cause of death all over the world. Irisin is a novel myokine released after exercise. This work aimed to study the correlation between the serum irisin level and the severity of the acute myocardial infarction in the exercise-trained rats. Methods Forty-eight male rats were classified into four groups (12 for each): group I, control sedentary (C); group II, exercise-trained (EX) (swimming for 8 weeks); group III, isoprenaline-induced infarct (MI); and group IV, exercise-trained infarct (EX-MI) (swimming for 8 weeks followed by isoprenaline-induced infarction). ECG was recorded at start and end of the study, before and after induction of infarction. The serum level of irisin, lipid peroxidation [malondialdehyde (MDA)], total antioxidant status (TAS), creatine phosphokinase-MB (CK-MB), and troponin I was determined. The hearts were excised for histopathology and immunohistochemistry for caspase-3. Results The infarct rats showed significant prolongation in QTc interval and elevation in the ST segment as well as significant elevation of serum CK-MB, troponin I, and MDA, whereas TAS and serum irisin level were significantly decreased. With exercise, we observed a high positive correlation between the serum irisin and QRS duration (+0.643), amplitude (+0.860), and TAS (+0.887). In addition, there was a high negative correlation between the serum irisin and ST elevation (-0.865), QTc (-0.886), CK-MB (-0.891), troponin (-0.882), and MDA (-0.868). This was confirmed by the negative correlation between serum irisin and both collagen deposition and caspase-3 expression (-0.823 and -0.822, respectively). Conclusions We recommend regular exercise or taking recombinant irisin as a supplement to protect at-risk individuals against acute myocardial infarction.

Entities:  

Keywords:  ECG; exercise; irisin; isoprenaline; myocardial infarction

Mesh:

Substances:

Year:  2018        PMID: 30265651     DOI: 10.1515/jbcpp-2018-0090

Source DB:  PubMed          Journal:  J Basic Clin Physiol Pharmacol        ISSN: 0792-6855


  6 in total

1.  Fibronectin type III domain-containing 5 in cardiovascular and metabolic diseases: a promising biomarker and therapeutic target.

Authors:  Xin Zhang; Can Hu; Hai-Ming Wu; Zhen-Guo Ma; Qi-Zhu Tang
Journal:  Acta Pharmacol Sin       Date:  2020-11-19       Impact factor: 7.169

2.  Effects of Swimming Exercise on Serum Irisin and Bone FNDC5 in Rat Models of High-Fat Diet-Induced Osteoporosis.

Authors:  Yun-Seok Kang; Jae-Cheol Kim; Jeong-Seok Kim; Sang Hyun Kim
Journal:  J Sports Sci Med       Date:  2019-11-19       Impact factor: 2.988

Review 3.  The Neuroprotective Effect of Irisin in Ischemic Stroke.

Authors:  Yaqiang Liu; Chunhua Zhu; Jiahui Guo; Yonghong Chen; Chaoyue Meng
Journal:  Front Aging Neurosci       Date:  2020-12-22       Impact factor: 5.750

4.  The Role of Interventional Irisin on Heart Molecular Physiology.

Authors:  Foad Alzoughool; Mohammad Borhan Al-Zghoul; Bayan Y Ghanim; Michael Gollob; Nasir Idkaidek; Nidal A Qinna
Journal:  Pharmaceuticals (Basel)       Date:  2022-07-14

Review 5.  Irisin at the crossroads of inter-organ communications: Challenge and implications.

Authors:  Renqing Zhao
Journal:  Front Endocrinol (Lausanne)       Date:  2022-10-04       Impact factor: 6.055

Review 6.  The Controversial Role of Irisin in Clinical Management of Coronary Heart Disease.

Authors:  Wen-Lu Ou-Yang; Bei Guo; Feng Xu; Xiao Lin; Fu-Xing-Zi Li; Su-Kang Shan; Feng Wu; Yi Wang; Ming-Hui Zheng; Qiu-Shuang Xu; Ling-Qing Yuan
Journal:  Front Endocrinol (Lausanne)       Date:  2021-07-01       Impact factor: 5.555

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.